Cargando…

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is a rare and complex endocrine disease characterized by hyperphagia and abnormal food-related behaviors that contribute to severe morbidity and early mortality and to a significant burden on patients and caregivers. Hyperghrelinemia may be involved in the underlying mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milano, Stephane, Allas, Soraya, Cade, Didier, Briffaux, Jean-Paul, Spencer, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550718/ http://dx.doi.org/10.1210/js.2019-MON-102

Ejemplares similares

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
por: Allas, Soraya, et al.
Publicado: (2018)

Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531
por: Au, CheukMan C, et al.
Publicado: (2020)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome
por: Kuppens, R. J., et al.
Publicado: (2015)

MON-093 Myokine Levels after Resistance Exercise in Young Adults with Prader-Willi Syndrome (PWS)
por: Hirsch, Harry, et al.
Publicado: (2019)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

SUN-595 Comparative Comorbidity Burden Among Patients with Prader-Willi Syndrome: A Population-Level Cohort Study
por: Stafford, Diane E J, et al.
Publicado: (2020)

OR10-2 Hormonal and Cardiometabolic Changes Associated with Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Abuzzahab, Jennifer, et al.
Publicado: (2022)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

RF24 | PSUN94 Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Woloschak, Michael, et al.
Publicado: (2022)

High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome
por: Beauloye, Veronique, et al.
Publicado: (2016)

Acquired Brain Injury-Induced Hyperphagia and Obesity, Successfully Treated With a GLP-1 Agonist
por: Ngu, Michael, et al.
Publicado: (2021)

Mice Deficient for an Intestinal G Protein-Coupled Receptor Expression Have Increased Satiety During Rebound Hyperphagia
por: Yan, Shijun, et al.
Publicado: (2021)

Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome
por: Polex-Wolf, Joseph, et al.
Publicado: (2018)

Hyperphagia and Obesity in Prader–Willi Syndrome: PCSK1 Deficiency and Beyond?
por: Ramos-Molina, Bruno, et al.
Publicado: (2018)

Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015)

Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome
por: Cho, Sung Yoon, et al.
Publicado: (2022)

Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader‐Willi syndrome
por: Kweh, Frederick A., et al.
Publicado: (2023)

SUN-102 Spexin Differentially Regulates Adipogenesis in Brown and White Adipose Tissue Depots
por: Sherman, Shermel, et al.
Publicado: (2019)

SUN-LB102 Development of a Conceptual Model to Present the Impacts of Obesity on Physical Functioning
por: Poon, Jiat Ling, et al.
Publicado: (2020)

MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020)

Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader–Willi syndrome
por: Davies, Jennifer R., et al.
Publicado: (2015)

Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome
por: Kayadjanian, Nathalie, et al.
Publicado: (2021)

The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome
por: Licenziati, Maria Rosaria, et al.
Publicado: (2022)

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

SAT-LB102 Obesity Is Associated With Reduced Expression of the Anorexigenic Neuropeptide Nucleobindin-2/Nesfatin-1 in the Human Nucleus of the Solitary Tract
por: Psilopanagioti, Aristea, et al.
Publicado: (2020)

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
por: Roof, Elizabeth, et al.
Publicado: (2023)

Analysis of Hyperphagia Questionnaire for Clinical Trials (HQ-CT) scores in typically developing individuals and those with Prader-Willi syndrome
por: Matesevac, Lisa, et al.
Publicado: (2023)

MON-111 Amenorrhea In Exercising Women Is Associated With A Greater Reduction In Post-prandial Ghrelin
por: Koltun, Kristen, et al.
Publicado: (2019)

MON-603 GPR142 Expression Levels Were Correlated with Plasma Ghrelin Levels and Heights in Morbidly Obese Patients
por: Ueda, Yoko, et al.
Publicado: (2020)

FRI074 Rise In Fasting Ghrelin Level In Response To Weight Loss Predicts Future Weight Regain In The POUNDS LOST Trial
por: Tong, Jenny, et al.
Publicado: (2023)

Three Siblings with Prader-Willi Syndrome: Brief Review of Sleep and Prader-Willi Syndrome
por: Bingeliene, Arina, et al.
Publicado: (2015)

Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS)
por: Ryman, Davis, et al.
Publicado: (2021)

MON-099 Age-Related Differences in Appetite Regulation among Adults with Obesity: More Than Just Hunger and PYY and Ghrelin? Oh My!
por: Iwamoto, Sean, et al.
Publicado: (2019)

Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
por: Cheon, Chong Kun
Publicado: (2016)

FRI008 Impact Of Sleep Fragmentation And Estradiol Suppression On Leptin, Ghrelin, Satiety And Hunger In Women: An Experimental Menopause Model To Understand Menopause-related Body Fat Gain
por: Rahman, Shadab A, et al.
Publicado: (2023)

Epigenetics in Prader-Willi Syndrome
por: Mendiola, Aron Judd P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nus8kljbh4fbrl5b04lamanv88